注射用克林霉素磷酸酯致神经肌肉阻滞1例分析

doi:10.19803/j.1672-8629.20240295

中国药物警戒 ›› 2024, Vol. 21 ›› Issue (10): 1178-1180.
DOI: 10.19803/j.1672-8629.20240295

注射用克林霉素磷酸酯致神经肌肉阻滞1例分析

张皓, 曹树刚, 贺军, 徐文安, 夏明武^*

合肥市第二人民医院神经内科,安徽合肥 230011

收稿日期:2024-05-08 出版日期:2024-10-15 发布日期:2024-10-14
通讯作者: ^*夏明武,男,本科,主任医师,脑小血管病。E-mail：xiamingwu1965@163.com
作者简介:张皓,男,硕士,住院医师,脑小血管病。

One case of neuromuscular block caused by clindamycin phosphate for injection

ZHANG Hao, CAO Shugang, HE Jun, XU Wenan, XIA Mingwu^*

Department of Neurology, Hefei Second People's Hospital, Hefei Anhui 230011, China

Received:2024-05-08 Online:2024-10-15 Published:2024-10-14

摘要/Abstract

摘要： 目的探讨注射用克林霉素磷酸酯致神经肌肉阻滞不良反应,为临床安全使用提供参考。方法结合相关文献,对1例51岁牙周脓肿患者应用注射用克林霉素磷酸酯后出现肌无力病例进行分析。结果患者使用替硝唑联合注射用克林霉素磷酸酯后出现肌无力,肌无力症状可能与注射用克林霉素磷酸酯有关,怀疑为注射用克林霉素磷酸酯导致的不良反应。经对症治疗后肌力基本恢复正常。结论临床发现肌无力症状时需考虑注射用克林霉素磷酸酯引起的可能性。对于合并使用神经肌肉阻滞药物的患者,注射用克林霉素磷酸酯应谨慎使用。

关键词: 克林霉素, 注射用, 神经肌肉阻滞, 肌无力, 药品不良反应

Abstract: Objective To investigate such adverse reactions as neuromuscular blockade caused by clindamycin phosphate for injection so as to provide references for clinical safe use. Methods Based on related literature, one case of myasthenia gravis in a 51-year-old patient with periodontal abscess after receiving clindamycin phosphate for injection was analyzed. Results The patient experienced muscle weakness after taking tinidazole and clindamycin phosphate for injection. The symptoms were considered to be adverse reactions related to clindamycin phosphate for injection. After symptomatic treatment, the patient's muscle strength was largely normalized. Conclusion In case of myasthenia gravis, the possibility of the symptoms being caused by clindamycin phosphate for injection should be considered. Clindamycin phosphate for injection should be used with caution in patients who are taking neuromuscular blocking drugs concurrently.

Key words: clindamycin, injection, neuromuscular blockade, muscle weakness, adverse drug reactions

中图分类号:

R978
R994.11

张皓, 曹树刚, 贺军, 徐文安, 夏明武. 注射用克林霉素磷酸酯致神经肌肉阻滞1例分析[J]. 中国药物警戒, 2024, 21(10): 1178-1180.

ZHANG Hao, CAO Shugang, HE Jun, XU Wenan, XIA Mingwu. One case of neuromuscular block caused by clindamycin phosphate for injection[J]. Chinese Journal of Pharmacovigilance, 2024, 21(10): 1178-1180.

导出引用管理器 EndNote|Ris|BibTeX

链接本文: https://zgywjj.magtechjournal.com/CN/10.19803/j.1672-8629.20240295

https://zgywjj.magtechjournal.com/CN/Y2024/V21/I10/1178

参考文献

[1] SHEIKH S, ALVI U, SOLIVEN B, et al.Drugs that induce or cause deterioration of myasthenia gravis: an update[J]. J Clin Med, 2021, 10(7): 1537.
[2] CRESCIOLI G, FINOCCHIETTI M, PAOLETTI O, et al.Potentially inappropriate drug use in myasthenia gravis: a real-world population-based cohort study in Italy[J]. Front Neurol, 2023, 14: 1293626.
[3] WU J, XU L.Analysis of clinical characteristics of three patients with serious adverse drug reactions caused by clindamycin phosphate[J]. Anti Infect Pharm(抗感染药学), 2023, 20(12): 1250-1252.
[4] SADIQ AM, MUKAMURI RR, KAMABU EM, et al.Thymoma: a fatal case report of recurring pneumonia from Tanzania[J]. Ann Med Surg(Lond), 2023, 85(4): 1018-1021.
[5] JEDEIKIN R, DOLGUNSKI E, KAPLAN R, et al.Prolongation of neuromuscular blocking effect of vecuronium by antibiotics[J]. Anaesthesia, 1987, 42(8): 858-860.
[6] BEST JA, MARASHI AH, POLLAN LD.Neuromuscular blockade after clindamycin administration: a case report[J]. J Oral Maxillofac Surg, 1999, 57(5): 600-603.
[7] AL AHDAL O, BEVAN DR.Clindamycin-induced neuromuscular blockade[J]. Can J Anaesth, 1995, 42(7): 614-617.
[8] WU G, WU G, WU H.A costly lesson: fatal respiratory depression induced by clindamycin during postoperative patient controlled analgesia[J]. Pain Physician, 2015, 18(3): E429-E431.
[9] LI H.A case report of limb weakness and sensory disturbance on the infusion side caused by clindamycin phosphate injection[J].Guide of China Medicine(中国医药指南), 2009, 7(21): 65-66.
[10] WANG J, CHI XX.Analysis of 2 cases of neuromuscular block caused by clindamycin hydrochloride[J]. Chin J of Clinical Rational Drug Use(临床合理用药杂志), 2016, 9(13): 176-177.
[11] BECKER LD, MILLER RD.Clindamycin enhances a nondepolarizing neuromuscular blockade[J]. Anesthesiology, 1976, 45(1): 84-87.
[12] JIA Y, ZHANG Y, ZHU H, et al.Design, synthesis, and bioactivity evaluation of clindamycin derivatives against multidrug-resistant bacterial strains[J]. Drug Dev Res, 2024, 85(3): e22182.
[13] CASILLAS AC, BARRAGAN VA, ALHALASEH Y, et al.Acute generalized exanthematous pustulosis associated with clindamycin in a patient with Hailey-Hailey disease[J]. J Cutan Pathol, 2023, 50(10): 864-868.
[14] LI XH, ZHANG D, WANG Q, et al.Quality analysis of clindamycin phosphate for injection[J]. Chinese Journal of Antibiotics(中国抗生素杂志), 2022, 47(2): 158-166.
[15] DU W, GUO JJ, JING Y, et al.Drug safety surveillance in China and other countries: a review and comparison[J]. Value Health, 2008, 11(Suppl 1): S130-S136.
[16] VANLINTHOUT LE, DRIESSEN JJ, STOLKER RJ, et al.Spontaneous recovery from neuromuscular block after a single dose of a muscle relaxant in pediatric patients: a systematic review using a network Meta-analytic and Meta-regression approach[J]. Paediatr Anaesth, 2024, 34(8): 720-733.
[17] KHANNA P, DAS A, SARKAR S.Coadministration of intravenous calcium along with neostigmine for rapid neuromuscular blockade recovery: a systematic review and Meta-analysis[J]. J Anaesthesiol Clin Pharmacol, 2024,40(1): 15-21.

注射用克林霉素磷酸酯致神经肌肉阻滞1例分析

One case of neuromuscular block caused by clindamycin phosphate for injection

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	孟康康, 夏玉坤. 昂丹司琼制剂安全性风险分析[J]. 中国药物警戒, 2024, 21(9): 1034-1038.
[2]	吴凡, 付林杰, 祝赫, 徐梦艳. 基于美国FAERS和日本JADER数据库的内皮素受体拮抗剂不良事件信号分析[J]. 中国药物警戒, 2024, 21(9): 1056-1063.
[3]	卢靖, 喻珊珊, 童菲, 林卓慧, 宋路瑶. 达格列净片致严重便秘1例分析[J]. 中国药物警戒, 2024, 21(9): 1071-1074.
[4]	刘婷, 曹忠强, 何文佳, 袁秀丽, 陈泽彬, 李学娟. 培门冬酶注射液致急性重症胰腺炎1例分析[J]. 中国药物警戒, 2024, 21(9): 1075-1077.
[5]	魏芬芳, 吴文宇, 李丽敏, 唐碧雨, 吴建茹. 国外药品获益-风险评价方法概述与启示[J]. 中国药物警戒, 2024, 21(8): 900-905.
[6]	王玉玺, 张宗林, 王颖丽, 陈亚飞, 李俊生, 霍艳飞, 谢彦军, 刘文启. 560例脉络舒通丸不良反应/事件报告分析[J]. 中国药物警戒, 2024, 21(8): 921-924.
[7]	赵俊, 董丽, 王洋, 梁瑜, 杨雪, 李恩泽. 艾司洛尔不良反应/事件报告分析[J]. 中国药物警戒, 2024, 21(8): 925-930.
[8]	张乾, 恽渊, 何恋. 1例利培酮致高泌乳素血症患者的药学监护[J]. 中国药物警戒, 2024, 21(8): 936-938.
[9]	晁滢, 张学梅, 张成健, 王贝. 注射用头孢曲松钠致儿童输尿管结石及胆囊结石1例分析[J]. 中国药物警戒, 2024, 21(8): 943-945.
[10]	郭海嬿, 何波, 闫鸿丽, 杨雪婷. 稳心颗粒致持续性呃逆1例分析[J]. 中国药物警戒, 2024, 21(8): 946-948.
[11]	王丹, 董铎, 田春华. 我国药物警戒制度发展历程和思考[J]. 中国药物警戒, 2024, 21(7): 735-740.
[12]	邵波, 郭晓昕. 中药药物警戒回顾与思考[J]. 中国药物警戒, 2024, 21(7): 741-745.
[13]	阿拉腾花, 王振兴, 张晓朦, 世伟, 席成伟, 王聪慧, 王立群, 张冰. 基于药品不良反应监测数据的心脏器官伤害风险信号挖掘分析[J]. 中国药物警戒, 2024, 21(7): 752-758.
[14]	程毅菁, 李涛, 刘军廷, 黄贵民, 钟旭丽, 林爱华, 潘守东, 李龙, 白东升, 占小俊, 刘振江, 任韡, 邰隽. 基于真实世界数据的注射用尖吻蝮蛇血凝酶儿童用药安全性评价[J]. 中国药物警戒, 2024, 21(7): 787-790.
[15]	赵杰, 高明娥, 常虹, 范惠霞. 复方聚乙二醇电解质散致患儿过敏样反应2例分析[J]. 中国药物警戒, 2024, 21(7): 816-818.